Nothing Special   »   [go: up one dir, main page]

DE60300339D1 - Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben - Google Patents

Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben

Info

Publication number
DE60300339D1
DE60300339D1 DE60300339T DE60300339T DE60300339D1 DE 60300339 D1 DE60300339 D1 DE 60300339D1 DE 60300339 T DE60300339 T DE 60300339T DE 60300339 T DE60300339 T DE 60300339T DE 60300339 D1 DE60300339 D1 DE 60300339D1
Authority
DE
Germany
Prior art keywords
cervical
solubilized
carcinomas
body sample
overexpression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60300339T
Other languages
English (en)
Other versions
DE60300339T2 (de
Inventor
Dr Ridder
Anja Dr Reichert
Matthias Dr Herkert
Knebel Doeberitz Magnus Dr Von
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche MTM Laboratories AG
Original Assignee
Roche MTM Laboratories AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche MTM Laboratories AG filed Critical Roche MTM Laboratories AG
Publication of DE60300339D1 publication Critical patent/DE60300339D1/de
Application granted granted Critical
Publication of DE60300339T2 publication Critical patent/DE60300339T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57411Specifically defined cancers of cervix
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
DE60300339T 2003-08-25 2003-08-25 Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben Expired - Lifetime DE60300339T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03103218A EP1507148B1 (de) 2003-08-25 2003-08-25 Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben

Publications (2)

Publication Number Publication Date
DE60300339D1 true DE60300339D1 (de) 2005-03-31
DE60300339T2 DE60300339T2 (de) 2006-04-13

Family

ID=33560881

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60300339T Expired - Lifetime DE60300339T2 (de) 2003-08-25 2003-08-25 Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben
DE602004026014T Expired - Lifetime DE602004026014D1 (de) 2003-08-25 2004-08-20 Verfahren zum Nachweis von medizinisch relevanten Zuständen in gelösten LBC-Proben

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE602004026014T Expired - Lifetime DE602004026014D1 (de) 2003-08-25 2004-08-20 Verfahren zum Nachweis von medizinisch relevanten Zuständen in gelösten LBC-Proben

Country Status (14)

Country Link
US (1) US7932047B2 (de)
EP (2) EP1507148B1 (de)
JP (2) JP5619336B2 (de)
CN (1) CN1836166B (de)
AT (2) ATE289685T1 (de)
AU (1) AU2004317284B2 (de)
BR (1) BRPI0414030B8 (de)
CA (1) CA2528490C (de)
DE (2) DE60300339T2 (de)
ES (1) ES2342535T3 (de)
HK (1) HK1092219A1 (de)
MX (1) MXPA05013903A (de)
RU (1) RU2405158C2 (de)
WO (2) WO2005088311A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601497B2 (en) 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
EP1510820B1 (de) * 2003-08-25 2010-03-17 MTM Laboratories AG Verfahren zum Nachweis von medizinisch relevanten Zuständen in gelösten LBC-Proben
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
EP2024520B1 (de) 2006-05-11 2014-03-05 Becton, Dickinson and Company Verfahren zur proteinextraktion aus zellen
US8968995B2 (en) 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US20100003704A1 (en) 2008-06-13 2010-01-07 Shuling Cheng IN SITU detection of early stages and late stages HPV infection
US9207240B2 (en) 2007-11-14 2015-12-08 Arbor Vita Corporation Method of efficient extraction of protein from cells
JP2011511271A (ja) * 2008-01-25 2011-04-07 サイトテック ラブズ リミテッド ライアビリティ カンパニー 腫瘍原性、腫瘍進行、および処置効率の査定のためのアッセイシステム
US20090204009A1 (en) * 2008-02-07 2009-08-13 Los Alamos National Security Medical device system and related methods for diagnosing abnormal medical conditions based on in-vivo optical properties of tissue
CA3117744C (en) 2008-09-04 2022-07-19 Ventana Medical Systems, Inc. Method for prediction of the progression risk of tumors
TWI419974B (zh) * 2008-10-27 2013-12-21 Qiagen Gaithersburg Inc 於自動平台上之快速結果雜交捕捉法
CN101487845B (zh) * 2009-02-19 2013-01-02 苏州海路生物技术有限公司 大便标本自动检测仪
EP2425019B1 (de) 2009-05-01 2014-03-19 QIAGEN Gaithersburg, Inc. Ungezieltes verstärkungsverfahren zur erkennung von rna-spleissformen in einer probe
EP2427763A4 (de) * 2009-05-07 2013-08-21 Oncohealth Corp Identifikation eines hohen cin2-grades zur erkennung von früh- und spätstadien sowie zum screening und zur diagnose des menschlichen papillomavirus (hpv) und mit diesem assoziierter krebserkrankungen
JP5819851B2 (ja) * 2010-01-08 2015-11-24 オンコヘルス コーポレーション Hpv関連の癌の治療及びスクリーニングのための細胞に基づいた高処理能力hpv免疫アッセイ
ES2615728T3 (es) 2010-01-29 2017-06-08 Qiagen Gaithersburg, Inc. Métodos y composiciones para una purificación y un análisis múltiple específico de secuencia de ácidos nucleicos
CA2787781A1 (en) 2010-01-29 2011-08-04 Qiagen Gaithersburg, Inc. Method of determining and confirming the presence of an hpv in a sample
JP2013528049A (ja) 2010-05-19 2013-07-08 キアゲン ガイサーズバーグ アイエヌシー. 核酸の配列特異的な精製及び多重分析のための方法及び組成物
WO2011149897A1 (en) 2010-05-25 2011-12-01 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically-truncated probes
JP5841941B2 (ja) * 2010-06-17 2016-01-13 国立大学法人 岡山大学 microRNA標的遺伝子検出用キット及びmicroRNA標的遺伝子の検出方法
GB201014335D0 (en) * 2010-08-27 2010-10-13 Forensic Science Service Ltd Improvements in and relating to analysis
NZ608814A (en) 2010-09-03 2015-06-26 Stem Centrx Inc Novel modulators and methods of use
CN102033056B (zh) * 2010-10-14 2012-05-30 中国科学院化学研究所 抑制膜蛋白受体聚集的抗癌药物鉴定方法
CA2828224A1 (en) 2011-02-24 2012-08-30 Qiagen Gaithersburg, Inc. Materials and methods for detection of hpv nucleic acids
BR112014011563B1 (pt) 2011-11-15 2022-05-24 University Of Miami Método para determinar um risco aumentado de carcinoma de células escamosas de cabeça e pescoço (hnscc) em um indivíduo humano infectado com papiloma vírus humano (hpv), e kit
RU2508542C1 (ru) * 2012-07-16 2014-02-27 Полина Михайловна Шварцбурд Экспресс-способ определения риска злокачественности клеток
RU2535071C1 (ru) * 2013-04-09 2014-12-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Ивановская государственная медицинская академия" Министерства здравоохранения Российской Федерации Способ диагностики недифференцированной дисплазии соединительной ткани у женщин с потерей беременности в анамнезе
WO2015017692A1 (en) * 2013-07-31 2015-02-05 University Of Miami Compositions and methods for identifying a risk of cancer in a subject
WO2015147370A1 (en) * 2014-03-28 2015-10-01 Seegene, Inc. Detection of target nucleic acid sequences using different detection temperatures
RU2558987C1 (ru) * 2014-04-21 2015-08-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ диагностики степени тяжести недифференцированной дисплазии соединительной ткани у женщин репродуктивного возраста
ES2806498T3 (es) 2015-06-08 2021-02-17 Arquer Diagnostics Ltd Métodos para el análisis de una muestra de orina
EP3304084B1 (de) 2015-06-08 2022-03-23 Arquer Diagnostics Limited Verfahren und kits
CN106610434A (zh) * 2016-02-26 2017-05-03 弗雷米德生物医药技术(天津)有限公司 一种hpv16型e7蛋白的elisa检测试剂盒
RU2680930C2 (ru) * 2017-03-24 2019-02-28 федеральное государственное бюджетное образовательное учреждение высшего образования "Северный государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ забора материала для цитологического исследования при опухолевых заболеваниях поджелудочной железы, печени и желчевыводящих путей
CN107748265A (zh) * 2017-09-29 2018-03-02 中南大学湘雅医院 Cdc6和ki67在制备癌症放疗抵抗的诊断标记物中的应用
MX2020006673A (es) * 2017-12-29 2020-08-31 Vertex Pharma Metodos de tratamiento del cancer mediante el uso de un inhibidor de ataxia-telangiectasia mutada y rad3 (atr).
US11230729B2 (en) 2018-04-20 2022-01-25 Inanna Diagnostics, Inc Methods and devices for obtaining cellular and DNA material from human female reproductive system
CN109781977B (zh) * 2019-01-09 2022-03-29 首都医科大学附属北京安定医院 IL15Rα以及相关膜蛋白检测试剂盒及其应用
RU2707099C1 (ru) * 2019-04-24 2019-11-22 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации Способ скрининга злокачественных опухолей органов грудной полости
MX2019005940A (es) * 2019-05-21 2019-10-11 Atso Corp Affairs S A De C V Biomarcadores relacionados a cancer.

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US5889169A (en) * 1991-05-16 1999-03-30 Cold Spring Harbor Laboratory Cell cycle regulatory protein p16 gene
EP0584264A1 (de) 1991-05-16 1994-03-02 Cold Spring Harbor Laboratory D-typ cyclin und darauf bezogene anwendungen
EP0643836B1 (de) * 1991-12-13 1999-09-08 Bion Diagnostic Sciences, Inc. Agglutierungsassays und kolloide farbstoffe verwendende testsätze
US6316208B1 (en) * 1994-01-07 2001-11-13 Memorial Sloan-Kettering Cancer Center Methods for determining isolated p27 protein levels and uses thereof
US6060301A (en) * 1994-03-18 2000-05-09 Myriad Genetics, Inc. Vector containing MTS1E1β gene
RU2161309C2 (ru) * 1994-03-18 2000-12-27 Исследовательский Фонд Университета Юты, Мутации гена мтs в зародышевой линии и способ выявления предрасположенности к злокачественным опухолям в гене мтs
US5989815A (en) * 1994-03-18 1999-11-23 University Of Utah Research Foundation Methods for detecting predisposition to cancer at the MTS gene
CA2164167A1 (en) 1994-12-20 1996-06-21 Izak Bahar Assay normalization method
US6033847A (en) * 1995-02-06 2000-03-07 St. Jude Children's Research Hospital InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof
US5843756A (en) * 1995-06-07 1998-12-01 Myriad Genetics, Inc. Mouse MTSI gene
US6403383B1 (en) * 1996-03-11 2002-06-11 American Bio Medica Corp. Diagnostic test kit for immunological assays of fluid samples
US5976799A (en) * 1996-03-21 1999-11-02 The Board Of Trustees Of The University Of Arkansas Early detection of ovarian carcinoma using P16 gene products
US5858683A (en) * 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer
WO1999004238A2 (en) 1997-07-15 1999-01-28 Mitotix, Inc. Reagents and methods for diagnosis and prognosis of proliferative disorders
US6090579A (en) * 1997-08-12 2000-07-18 Smithkline Beecham Corporation Human SDR2 cDNA clone
WO1999029890A2 (en) * 1997-12-12 1999-06-17 Digene Corporation Assessment of human papilloma virus-related disease
US20010051364A1 (en) * 1997-12-23 2001-12-13 Francis Michon Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines
US6686151B1 (en) 1998-02-06 2004-02-03 Digene Corporation Immunological detection of RNA:DNA hybrids on microarrays
US7399589B2 (en) * 1998-02-06 2008-07-15 Digene Corporation Immunological detection of RNA:DNA hybrids on microarrays
US5994079A (en) * 1998-02-06 1999-11-30 Digene Corporation Direct detection of RNA mediated by reverse transcriptase lacking RNAse H function
US6576420B1 (en) * 1998-06-23 2003-06-10 Regents Of The University Of California Method for early diagnosis of, and determination of prognosis in, cancer
US7306926B2 (en) * 1998-07-01 2007-12-11 Mtm Laboratories Ag Method for detecting carcinomas in a solubilized cervical body sample
DE19829473C2 (de) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
EP1388734B1 (de) * 2002-08-01 2004-03-03 MTM Laboratories AG Verfahren für Lösung-basierte Diagnose
US6593084B2 (en) * 1998-10-13 2003-07-15 Robert E. Bird Carcinogen assay
WO2000031538A1 (en) * 1998-11-23 2000-06-02 Praxsys Biosystems, Inc. Improved lateral flow assays
SE515668C2 (sv) * 1999-02-22 2001-09-17 Quantovir Ab Metod och kit för tidig förutsägelse av cancer
DE10014685B4 (de) * 2000-03-24 2004-07-01 Schubert, Walter, Dr. Verfahren zur Identifizierung von zellspezifischen Zielstrukturen
GB0018140D0 (en) 2000-07-24 2000-09-13 Medical Res Council Screening for abnormalities
DE10063179A1 (de) 2000-12-18 2002-06-20 Bayer Ag Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
ITRM20010363A1 (it) * 2001-06-25 2001-09-24 Franco Castelmani Gancio adattivo applicato ad un generatore di vivrazioni sinusoidali.
IL162722A0 (en) * 2002-01-07 2005-11-20 Norchip As Method for detecting human papillomarirus mrna
EP1333278B1 (de) * 2002-02-01 2004-03-10 MTM molecular tools in medicine Verfahren zur Prognose gastrointestinaler Tumoren
US7361460B2 (en) * 2003-04-11 2008-04-22 Digene Corporation Approach to molecular diagnosis of human papillomavirus-related diseases

Also Published As

Publication number Publication date
US20070190529A1 (en) 2007-08-16
MXPA05013903A (es) 2006-03-09
BRPI0414030B1 (pt) 2017-04-04
EP1664788A1 (de) 2006-06-07
WO2005088311A1 (en) 2005-09-22
JP5619336B2 (ja) 2014-11-05
RU2006101395A (ru) 2006-06-10
DE602004026014D1 (de) 2010-04-29
AU2004317284B2 (en) 2009-11-05
EP1507148B1 (de) 2005-02-23
HK1092219A1 (en) 2007-02-02
CA2528490A1 (en) 2005-09-22
BRPI0414030B8 (pt) 2021-07-27
ES2342535T3 (es) 2010-07-08
EP1507148A1 (de) 2005-02-16
WO2005084103A2 (en) 2005-09-15
RU2405158C2 (ru) 2010-11-27
BRPI0414030A (pt) 2007-01-23
AU2004317284A1 (en) 2005-09-22
ATE461449T1 (de) 2010-04-15
CN1836166A (zh) 2006-09-20
JP2012032412A (ja) 2012-02-16
JP5677270B2 (ja) 2015-02-25
CN1836166B (zh) 2010-05-26
DE60300339T2 (de) 2006-04-13
JP2007503208A (ja) 2007-02-22
CA2528490C (en) 2015-11-03
ATE289685T1 (de) 2005-03-15
US7932047B2 (en) 2011-04-26

Similar Documents

Publication Publication Date Title
ATE289685T1 (de) Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
MX2007005053A (es) Metodo para evaluar la enfermedad de alzheimer y reactivo de diagnostico.
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
PH12020551371A1 (en) Assays to detect neurodegeneration
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
ATE418072T1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
MXPA05006382A (es) Uso de nicotinamida n-metiltransferasa como un marcador para cancer colorrectal.
SI1977244T1 (sl) Razlikovanje med bakterijskim meningitisom in virusnim meningitisom
MY145455A (en) Diagnostic biomolecule(s)
WO2005040806A3 (en) Use of protein asc as a marker for breast cancer
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
ATE557277T1 (de) Verfahren zur diagnose von endometriose mittels tfpi-2 protein
EP1636587A4 (de) Einen für menschliches protoonkogenes protein spezifischen antikörper enthaltender diagnostischer kit für leberzirrhose
AU2490102A (en) Method for diagnosing a tumor in a patient determining the concentration of pibf
EA201001340A1 (ru) Улучшенный аналитический способ для определения латентного гепатита с, его применения и соответствующий диагностический набор
WO2006112962A3 (en) Syphilis diagnostic test and kits
ATE410691T1 (de) Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome
WO2005040807A3 (en) Swiprosin-2 as a breast cancer marker
SG152020A1 (en) Diagnostic methods

Legal Events

Date Code Title Description
8364 No opposition during term of opposition